"Healthcare Requires a Strong Will", "Correct Data: A Prerequisite for Correct Decisions", "Lessons from the Economic Crisis"
SfEE’s Position on the Price Determination System
Press Release
Halandri, February 17, 2010
Following the Government’s announcement on the new price determination system for medicinal products, the Hellenic Association of Pharmaceutical Companies (SfEE), would like to make the following remarks:
Since the initiation of a public dialogue by the government, SfEE has proven in practice through the integrated proposals it supplied, that it firmly supports the measures designed to contain health expenditure and overspending. The government’s decisions on the new price determination system, which resulted after several months of deliberations, are to the right direction although the prices of medicines are compressed to a marginal level.
Translation of Press Release by the Ministry of Economy about the Medicinal Products Price Determination Policy
A Report on Hospital Debts
The Pharmaceutical Market in Greece
Annual Report 2009 (Executive Summary), ΙΟΒΕ
Pharmaceuticals and Health Care: A Step Ahead
Dionysios Filiotis, SFEE President
SFEE's Publications
-
-
SFEE Profile 2009
-
Code of Practice of SFEE - Synopsis
-
The Pharmaceutical Market in Greece: Facts & Figures, Athens 2008
PRESS RELEASES
-
SfEE's Position on the Price Determination SystemFebruary 17, 2010
-
Falsified (Counterfeit) Medicines: Greece is “armored” - Europe is faced with a big problemDecember 8, 2009
-
General Assembly of SFEE – Board members electedApril 6, 2009
ARTICLES-INTERVIEWS
-
"Pharmaceuticals and Health Care: A Step Ahead"Article by Mr. D. Filiotis, President of SFEE
BUSINESS PARTNERS
November–December 2009, Vo. VIII/No. 45 -
"An opportunity for change in the health sector"Statement by Mr. D. Filiotis, President of SFEE
NEWS
- 2009, October 27 - 13:06 Transatlantic Administrative Simplification Action Plan – 2009 implementation reportDuring the recent annual EU-EMEA/FDA bilateral meeting the parties took stock of the progress achieved regarding the implementation of the Transatlantic Administrative Simplification Action Plan, agreed in June 2008.
- 2009, October 12 - 09:42 Assessment of the functioning of the "Clinical Trials Directive” 2001/20/EC - Public consultation paperIn its Communication of 10 December 2008 to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on “Safe, Innovative and Accessible Medicines: a Renewed Vision for the Pharmaceutical Sector”1, the Commission announced that an assessment would be made of the application of Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use2 (“Clinical Trials Directive”). This assessment would consider, in particular, various options for further improving the functioning of the Clinical Trials Directive with a view to remedy shortcomings and unintended negative consequences while taking the global dimension of clinical trials into account.
- 2009, September 29 - 16:25 Commission paves the way for vaccinations for influenza pandemic (H1N1) 2009Following the positive scientific opinion issued by the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMEA) on 24 September, today the European Commission granted variations to two existing authorisations for vaccines for influenza pandemic (H1N1) 2009. The products concerned are Focetria® (Novartis), and Pandemrix® (GlaxoSmithKline). The vaccines will be authorised for use in all Member States of the EU and the EEA (Iceland, Liechtenstein and Norway). That should ensure that sufficient vaccines will be available before the start of the flu season and will reduce the risks for illnesses and deaths for European Citizens.
- 2009, September 29 - 10:05 MRL - Substances considered as not falling within the scope of Council Regulation (EC) No. 470/2009 (Revision 17)Rivision 17 of the document Substances considered as not falling within the scope of Council Regulation (EC) No. 470/2009 (September 2009) is now available.
English
Ελληνικά
